STERIS CORPORATION

Lobbying for STERIS CORPORATION

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Ohio · House · Senate · $110,000.00 expenses · posted Apr 20, 2026

Lobbying activity 4

Health Issues

FDA regulations and MDUFA Reauthorization

Environment/Superfund

Sterilization

Manufacturing

Supply chain issues.

Trade (domestic/foreign)

Tariffs, USMCA

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.